Reports By Brokerage: HDFC Sec
Thematic report on the Hotels Sector (Indian Hotels & Lemon Tree) by HDFC Sec | |
Company: | Indian Hotels, Lemon Tree Hotels, Model Portfolio |
Brokerage: | HDFC Sec |
Date of report: | January 27, 2023 |
Type of Report: | Sector Report |
Recommendation: | Buy |
Upside Potential: | 44% |
Summary: | India’s hotel industry has witnessed a robust turnaround in demand after the pandemic, led by the rising discretionary spending on tours and travels, revenge tourism, improving economic environment fuelling corporate travels and revival of mega wedding season and other cultural events |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: HDFC Sec
Bajaj Finance Correction offers an attractive entry; upgrade to ADD for Target Price INR 6,700: HDFC Sec | |
Company: | Bajaj Finance |
Brokerage: | HDFC Sec |
Date of report: | January 28, 2023 |
Type of Report: | Result Update |
Recommendation: | Buy |
Upside Potential: | 16% |
Summary: | Bajaj Finance (BAF) delivered a strong operating performance, with steady NIMs in a rising interest rate and strong AUM growth (+27% YoY) environment. |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: HDFC Sec
Equity MF Performance Summary by HDFC Securities | |
Company: | Mutual Funds |
Brokerage: | HDFC Sec |
Date of report: | January 13, 2023 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | Equity MF Performance Summary by HDFC Securities |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: HDFC Sec
Buy Gujarat Themis Biosyn for target price of Rs 909: HDFC Securities | |
Company: | Gujarat Themis Biosyn |
Brokerage: | HDFC Sec |
Date of report: | January 2, 2023 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 17% |
Summary: | Prior to FY20, company was engaged in contract manufacturing of Rifamycin S for Lupin. During FY20, management decided to change business model from contract manufacturing to manufacturing and sales model; as a result the company’s operating profitability has significantly improved. Company had reported robust numbers over FY20-22 |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: HDFC Sec
Latest List Of High Dividend Yield Stocks (28 December 2022) By HDFC Sec | |
Company: | Model Portfolio |
Brokerage: | HDFC Sec |
Date of report: | December 28, 2022 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 14.6% |
Summary: | table of companies (CNX 500 stocks) that offer dividend yield of 3.00% and above |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: HDFC Sec
Taxfree & Taxable bonds Retail NCD Reckoner by HDFC Securities | |
Company: | Taxfree & Taxable bonds Retail NCD Reckoner |
Brokerage: | HDFC Sec |
Date of report: | December 16, 2022 |
Type of Report: | Techno-Funda |
Recommendation: | Buy |
Upside Potential: | 9.27% |
Summary: | In Tax Free Bonds, to avail (or retain) the 25bps additional in the coupon rate, Investors should be aware that the total investment in the aggregate face value of Bonds held by the Bondholders in all the Series of Bonds, allotted under the relevant Tranche Issue shall be clubbed and taken together and that should be up to Rs. 10 Lakhs |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: HDFC Sec
Catalysts for growth in place for Chemicals stocks. Seven stocks to buy: HDFC Securities | |
Company: | Model Portfolio, Specialty Chemicals |
Brokerage: | HDFC Sec |
Date of report: | December 5, 2022 |
Type of Report: | Sector Report |
Recommendation: | Buy |
Upside Potential: | 46% |
Summary: | The chemical industry’s growth is not hostage to any one economic parameter or any one end-user industry. Rising domestic demand and the need to evolve have forced domestic chemical companies to expand their capacities to remain competitive. Our positive stance on the sector is backed by its strong growth, aided by diversity in terms of chemistries and/or technologies |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: HDFC Sec
Devyani International riding on the strong business momentum in core brand business. Buy for target of Rs 220: HDFC Securities | |
Company: | Devyani International Ltd |
Brokerage: | HDFC Sec |
Date of report: | November 30, 2022 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 18% |
Summary: | A strong recovery in the out-of-home consumption, rising traction for branded products, aggressive store expansion plans, value proposition through an innovated menu and widening delivery reach will help DIL’s revenues clock a CAGR of 36% over FY22-24E (~23% increase due to store count) |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: HDFC Sec
ROLLOVER ANALYSIS. REMAIN BULLISH AND USE ANY CORRECTIONS TO ACCUMULATE LONG POSITIONS WITH SL OF 18000: HDFC Sec | |
Company: | Model Portfolio |
Brokerage: | HDFC Sec |
Date of report: | November 25, 2022 |
Type of Report: | Techno-Funda |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | To Sum it up, Lower stock Futures’ Open Interest (compared to all time highs), Lower Open Interest in the Nifty Futures’ as compared to last 17 year average OI of 2.08 Cr shares despite Nifty near all time highs, FIIS long to short ratio in the Index Futures at 3.28 (Aggressive Long build up by FIIS in the Index Futures segment), aggressive Put writing at 18000 levels and strong recovery in the global markets from the recent lows indicates that downside is limited in the Nifty and one should remain optimistic for the December series also. |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: HDFC Sec
AXIS Bank is on track to deliver steady performance. Buy for target price of Rs 1195 (35% upside): HDFC Securities | |
Company: | Axis Bank |
Brokerage: | HDFC Sec |
Date of report: | November 25, 2022 |
Type of Report: | Result Update |
Recommendation: | Buy |
Upside Potential: | 35% |
Summary: | AXSB finally seems to be on track to deliver steady performance with lower shocks. While the bank is on track to deliver ~14-15% RoE over the next couple of years, we argue that enhanced productivity and gradual exercising of pricing power in chosen segments could drive sustained medium-term RoEs. We argue for a gradual convergence in valuation multiples with ICICIBC |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |